February 11, 2026

FDA Rejects Moderna’s Experimental Flu Vaccine Over Trial Standard Concerns

The Food and Drug Administration (FDA) has denied a review to the pharmaceutical giant Moderna over its latest experimental flu vaccine. The post FDA Rejects Moderna’s Experimental Flu Vaccine Over Trial Standard Concerns appeared first on The Gateway Pundit.

FDA Rejects Moderna’s Experimental Flu Vaccine Over Trial Standard Concerns

TL;DR

  • The FDA denied a review for Moderna's experimental flu vaccine.
  • Objections were raised regarding the trial's benchmark comparison against the less effective Fluarix Quadrivalent.
  • The FDA's chief vaccine official stated the trial was not sufficiently "adequate and well-controlled."
  • Moderna's CEO expressed frustration, claiming no safety or efficacy concerns were identified and accusing the FDA of hindering innovation.
  • Moderna plans to engage with the FDA to determine the next steps for their vaccine.

Continue reading the original article

Made withNostr